BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, July 24, 2026
Home
»
Newsletters
» BioWorld
BioWorld
April 10, 2003
View Archived Issues
A Chain Of Fanconi Anemia Genes Links To Ovarian Cancer Cells Via Odd BRCA Breast Cancer Genes
Read More
Canadian Companies Inflazyme, GlycoDesign Plan C$12.8M Merger
Read More
Antigenics' Leukemia Vaccine AG-858 Enters Phase II Study
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
SangStat's Ulcerative Colitis Drug Positive In Phase II, Fails Crohn's
With a new CEO installed and a recent favorable court ruling, SangStat Medical Corp. chalked up more good news Wednesday: positive preliminary Phase II data with RDP58, its drug for ulcerative colitis. (BioWorld Today)
Read More
Administration Seeks Support For Countermeasures Program
Read More
